Global Surgical Equipment Market 2021-2025

Global Surgical Equipment Market 2021-2025:  The “Surgical Equipment: Technologies and Global Markets 2020-2025” report has been added to ResearchAndMarkets.com’s offering.

This research report presents an in-depth analysis of the surgical equipment market, including forecasted trends and sales through 2025 Key market participants, extensive product segments, supporting technologies, trends and market dynamics, competitive intelligence and regional trends are discussed in the report.

This report analyzes key market dynamics and changes in the surgical equipment market due to the pandemic. The report discusses various supply chain participants (manufacturers, suppliers, retailers and hospitals). Key trends, market estimates, significant strategies among stakeholders, product portfolios and recent developments will be presented in detail. An in-depth patent analysis is presented in the report and focuses on the development of extensive technological trends across regions (i.e., the U.S., Europe and Japan).

This report presents a market analysis and estimates for the broad range of surgical equipment across key therapeutic segments: cardiovascular, neurology, gynecology and urology orthopedics. It excludes supporting devices such as anesthesia systems, sterilization equipment, diagnostic systems, integrated robotic systems and implants.

The report includes:

  • 271 data tables and 42 additional tables
  • An overview of the global market and technologies for general surgical equipment
  • Estimation of the market size and analyses of global market trends, with data from 2019, 2020 and projections of compound annual growth rates (CAGRs) through 2025
  • Information on the global surgical equipment market structure and technological innovations such as surgical robotics, powered surgical tools, and a significant focus on minimally invasive procedures
  • Insights into healthcare regulations, policies and implications; and discussion on regulated or proposed to be regulated medical devices
  • Quantification and estimation of market revenues and dynamics for the global surgical equipment market and its segments, by product, usability, supply chain and technology
  • Study of the factors impacting market growth and analyze trends and opportunities in major regions, and the trends, gaps and opportunities in each micro market
  • Coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
  • Discussion of the impact of COVID-19 on micro and macro environment factors that influence surgical equipment markets
  • Company profiles of the market leading participants, including Becton, Dickinson and Co., ConMed, Hologic Inc., Johnson & Johnson and Medtronic PLC

Key Topics Covered:

Chapter 1 Introduction

Chapter 2 Summary and Highlights

Chapter 3 Market Overview

  • Hospital Budgets: Developed vs. Developing Economies
  • Developed Countries
  • Developing Countries
  • Healthcare Regulations, Policies and Implications
  • Technological Innovations and Trends
  • Rising Number of Patents
  • Rapid Advancements in Technology
  • Recent Innovations
  • Supply Chain Process and Market Analysis
  • Disposable vs. Reusable
  • Disposable Instruments
  • Reusable Instruments
  • Market Analysis
  • Product Launches and Acquisition
  • Current Environment, Future Trends and Strategic Conclusions
  • Factors Driving Expansion of the Market

Chapter 4 Global Surgical Equipment Market Dynamics

  • Market Drivers
  • Increase in Minimally Invasive Procedures
  • Increased Demand for Surgical Equipment
  • Increase in Outpatient Surgeries
  • Restraints and Challenges
  • Untrained End Users
  • Regulatory Environment
  • Continuing Demand for Specialized Instruments
  • Quality Standards
  • Opportunities
  • Emerging Economies
  • Replenishment in Developed Economies
  • Impact of COVID-19 on the Surgical Equipment Market
  • Impact of COVID-19 on Elective Surgery
  • Priority Levels of Surgeries
  • Pre-surgery Formalities

Chapter 5 Global Market for Surgical Equipment by Product Category

Chapter 6 Surgical Equipment: Conventional versus Disposable

  • Disposable Surgical Equipment
  • Decontamination and Sterilization
  • Risk Management
  • Instrument Traceability
  • Logistics and Supplies
  • Cost Allocation
  • Environmental Impact
  • Cost
  • Reusable Surgical Equipment
  • Healthcare-Associated Infections

Chapter 7 Global Market for Surgical Equipment by Supply Chain

  • Market Players: Manufacturers/Dealers, Distributors and Retailers
  • End Users: Small Clinics, Medium-Level Specialty Hospitals, Large Hospitals and Others
  • Strategic Recommendations

Chapter 8 Global Market for Surgical Equipment Market by Technology

  • Electrosurgical Equipment
  • Technological Advances
  • Doctor’s Office Procedures
  • Manual Surgical Equipment
  • Wireless Surgical Equipment

Chapter 9 Global Market for Surgical Equipment by Region

  • North America
  • Europe
  • Asia-Pacific
  • COVID-19 and the Asia-Pacific-Pacific Market
  • Rest of the World (ROW)

Chapter 10 Competitive Landscape

  • Product Launches
  • Mergers and Acquisitions
  • Agreements, Partnerships, Collaborations and Joint Ventures

Chapter 11 Miscellaneous Markets and Estimates

Chapter 12 Patent Analysis

  • U.S.
  • Europe
  • Japan
  • Patent Analysis 2006-July 2013: Historical Perspective
  • U.S. Patents
  • European Patents
  • Japanese Patents

Chapter 13 Company Profiles

  • Aesculap
  • B. Braun Melsungen Ag
  • Becton, Dickinson and Co. (Carefusion Corp.)
  • Bien-Air Medical Technologies
  • Boston Scientific
  • Brasseler Usa
  • Conmed
  • Erbe Usa Inc.
  • Hologic Inc.
  • Johnson & Johnson (Codman & Shurtleff Inc.)
  • Medtronic Plc
  • Olympus Corp.
  • Smith & Nephew Plc (Arthrocare Corp.)
  • Stryker
  • Zimmer Biomet

Chapter 14 List of Patents

  • Patents Granted from 2006-July 2013

For more information about this report visit here.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”